InsidersTradesSigma
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (24 ops.)
Insider track record
CFODisclosed buys
7
Disclosed sells
24
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by STANKOVICH THOMAS, Chief Financial Officer. Director active across 1 company, notably ReShape Lifesciences Inc.. Cumulatively, 36 filings have been published. Breakdown: 7 buys · 24 sells. Total volume traded: €337k. History available since 15 June 2021. The latest transaction was filed on 30 November 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations36 total
39 shares@ US$0.230.0% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-24-000059:0
108 shares@ US$1.430.0% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-23-000110:0
106 shares@ US$1.470.0% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-23-000077:0
109 shares@ US$2.600.1% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-23-000075:0
48 shares@ US$7.490.1% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-23-000030:0
364,756 shares0Common Stock, $0.001 par value per shareSEC:0001235802-22-000136:0
5,883 shares@ US$0.27250.5% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000119:0
5,809 shares@ US$0.28070.5% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000112:0
4,828 shares@ US$0.390.5% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000109:0
4,728 shares@ US$0.470.6% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000092:0
4,630 shares@ US$0.550.7% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000081:0
4,478 shares@ US$0.961.2% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000077:0
78 shares@ US$0.870.0% of flowCommon Stock, $0.001 par value per shareSEC:0001104659-22-067045:0
Ideal exit: 25 Feb 2023 (T+270)
4,529 shares@ US$0.770.9% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000058:0
5,038 shares@ US$1.131.5% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000045:0
3,658 shares@ US$1.061.0% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000035:0
3,684 shares@ US$1.221.2% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000021:0
3,684 shares@ US$1.221.1% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000021
3,171 shares@ US$1.781.4% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000019:0
3,171 shares@ US$1.781.4% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000019
4,304 shares@ US$1.8271.9% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-21-000140
4,304 shares@ US$1.8272.0% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-21-000140:0
20,000 shares@ US$2.0210.2% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-21-000132:0
Ideal exit: 15 Aug 2022 (T+270)
20,000 shares@ US$2.029.9% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-21-000132
Ideal exit: 15 Aug 2022 (T+270)
4,320 shares@ US$2.692.8% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-21-000130
25 of 36 declarations
About STANKOVICH THOMAS
Thomas Stankovich is an executive at ReShape Lifesciences Inc.
